Connection
David Hall to Biomarkers, Tumor
This is a "connection" page, showing publications David Hall has written about Biomarkers, Tumor.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
0.390 |
|
|
|
-
De La O JP, Hoag JR, Deem AK, Wang M, Starodynov A, Udhane SS, LoBello JR, Therala N, Hall DW, Basu GD, Baehner FL. Comprehensive genomic profiling of over 10,000 advanced solid tumors. Oncotarget. 2025 07 25; 16:587-603.
Score: 0.134
-
Diergaarde B, Young G, Hall DW, Mazloom A, Costa GL, Subramaniam S, Palomares MR, Garces J, Baehner FL, Schoen RE. Circulating Tumor DNA as a Marker of Recurrence Risk in Stage III Colorectal Cancer: The a-CORRECT Study. J Surg Oncol. 2025 Jul; 132(1):175-186.
Score: 0.130
-
Kundranda MN, Kemkes AC, Evans MC, Flannery CA, Hall DW, Hoag JR, Therala N, Thakkar SG, De La O JP. Associations with other cancer-related biomarkers might contribute to poor outcomes in RAS-altered, younger patients with colorectal cancer. Oncologist. 2024 09 06; 29(9):e1228-e1230.
Score: 0.126
|
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
|